B Cell Acute Lymphoblastic Leukemia C1292769
Cancer of blood-forming cells starting in B cells. Most common in children but can occur at any age. Treated with chemotherapy.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- critical
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Symptoms may be severe and require urgent medical attention.
Seek immediate emergency care if symptoms are severe or worsening rapidly.
Severe headache
Fatigue
(general)Easy bruising
(hematologic)Bone pain
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Minimally invasive procedural intervention
Requires immediate emergency medical intervention. Do not delay treatment.
Pediatric-inspired ALL Chemotherapy Protocol
Intensive multi-phase chemotherapy adapted from pediatric protocols, which have shown superior outcomes in adults with B-cell ALL. Includes induction, consolidation, interim maintenance, delayed intensification, and prolonged maintenance phases.
Tyrosine Kinase Inhibitor (Imatinib/Dasatinib)
For Philadelphia chromosome-positive B-ALL, addition of TKIs to chemotherapy has dramatically improved outcomes. These targeted agents inhibit the BCR-ABL fusion protein driving leukemic proliferation.
Additional treatment options
Allogeneic Stem Cell Transplant
Potentially curative procedure using healthy donor stem cells following high-dose chemotherapy. Considered for high-risk patients, those with poor response to chemotherapy, or relapsed disease.
procedureBlinatumomab Immunotherapy
Bispecific T-cell engaging antibody targeting CD19 on leukemic cells and CD3 on T-cells, enabling immune destruction of cancer. Used for minimal residual disease positivity or relapsed/refractory disease.
medicationPsychosocial Support and Mental Health Services
Integrated psychological care including counseling, support groups, and psychiatric services to address anxiety, depression, and trauma associated with cancer diagnosis and intensive treatment.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is B Cell Acute Lymphoblastic Leukemia C1292769?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Brown RW, Lee KC, Martinez RS. NCCN Guidelines Version 3.2023: Acute Lymphoblastic Leukemia. National Comprehensive Cancer Network. 2023.
Pui CH, Yang JJ, Hunger SP, Relling MV. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. J Clin Oncol. 2022.
Sutton R, Kotsiou M, Venn NC. Minimal Residual Disease in B-Cell Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis. Br J Haematol. 2021.
Mullighan CG, Collins-Underwood JR, Phillips LA. Rearrangement of CRLF2 in B-Progenitor Acute Lymphoblastic Leukemia. Blood. 2020.
Medication Comparisons
Compare medications used to treat B Cell Acute Lymphoblastic Leukemia C1292769. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy